1. Home
  2. AOUT vs CHRS Comparison

AOUT vs CHRS Comparison

Compare AOUT & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Outdoor Brands Inc.

AOUT

American Outdoor Brands Inc.

HOLD

Current Price

$8.37

Market Cap

91.1M

Sector

Industrials

ML Signal

HOLD

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.35

Market Cap

186.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOUT
CHRS
Founded
2020
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.1M
186.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
AOUT
CHRS
Price
$8.37
$1.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$12.50
$4.02
AVG Volume (30 Days)
99.5K
963.8K
Earning Date
12-09-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.34
Revenue
$207,348,000.00
$277,728,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.08
$67.29
P/E Ratio
N/A
$1.02
Revenue Growth
2.85
152.07
52 Week Low
$6.26
$0.71
52 Week High
$17.91
$1.89

Technical Indicators

Market Signals
Indicator
AOUT
CHRS
Relative Strength Index (RSI) 71.38 51.35
Support Level $7.57 $1.31
Resistance Level $8.10 $1.41
Average True Range (ATR) 0.42 0.09
MACD 0.13 0.02
Stochastic Oscillator 98.86 68.93

Price Performance

Historical Comparison
AOUT
CHRS

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

Share on Social Networks: